Keith Stewart, MB ChB, Kathleen Colson RN, BSN, BS, Charise Gleason MSN, NP-BC, AOCNP, Wendy Vogel, MSN, FNP, AOCNP

Less Than Half of Recently Approved Cancer Drugs Show a Clinical Benefit

Cadonilimab Plus Chemo Provides Survival Benefit in Gastric/GEJ Cancer

Lenvatinib Plus Pembrolizumab Improves Survival in Advanced/Recurrent Endometrial Cancer

Frontline Durvalumab Regimen Improves PFS, Responses in Advanced Endometrial Cancer